A study by The Menges Group found that $74.4 billion would be saved over a decade by changes to Medicaid drug benefit programs that include greater use of generics, limited pharmacy networks and negotiation of dispensing fees. The report, sponsored by the Pharmaceutical Care Management Association, said the savings for the federal government would total $43 billion, while states would save $31.4 billion.

Related Summaries